Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study REPLY

被引：0
|
作者：
Derweesh, Ithaar H. [1 ]
Stroup, Sean P. [1 ]
Millard, Frederick [2 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Surg, Div Urol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Internal Med, Div Med Oncol, La Jolla, CA 92093 USA
来源：
UROLOGY | 2013年 / 81卷 / 04期
关键词：
D O I：
10.1016/j.urology.2012.10.058
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：812 / 812
页数：1
相关论文
共 50 条
  • [31] Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma
    Stadler, WM
    Kuzel, T
    Shapiro, C
    Sosman, J
    Clark, J
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2541 - 2545
  • [32] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Onal, Cem
    Oymak, Ezgi
    Guler, Ozan Cem
    Tilki, Burak
    Yavas, Guler
    Hurmuz, Pervin
    Yavas, Cagdas
    Ozyigit, Gokhan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (05) : 456 - 464
  • [33] Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
    Cem Onal
    Ezgi Oymak
    Ozan Cem Guler
    Burak Tilki
    Guler Yavas
    Pervin Hurmuz
    Cagdas Yavas
    Gokhan Ozyigit
    Strahlentherapie und Onkologie, 2023, 199 : 456 - 464
  • [34] Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database
    Park, Changsu Lawrence
    Moria, Feras Ayman
    Ghosh, Sunita
    Wood, Lori
    Bjarnason, Georg A.
    Bhindi, Bimal
    Heng, Daniel Yick Chin
    Castonguay, Vincent
    Pouliot, Frederic
    Kollmannsberger, Christian K.
    Bosse, Dominick
    Basappa, Naveen S.
    Finelli, Antonio
    Fallah-rad, Nazanin
    Breau, Rodney H.
    Lalani, Aly-Khan A.
    Tanguay, Simon
    Graham, Jeffrey
    Saleh, Ramy R.
    CURRENT ONCOLOGY, 2024, 31 (08) : 4704 - 4712
  • [35] THE IMPACT OF KINETICS OF BIOMARKERS ON THE PREDICTION OF OVERALL SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH A TYROSINE KINASE INHIBITOR
    Teishima, Jun
    Ohara, Shinya
    Sadahide, Kousuke
    Fujii, Shinsuke
    Kitano, Hiroyuki
    Shinmei, Shunsuke
    Hieda, Keisuke
    Inoue, Shogo
    Hayashi, Tetsutaro
    Mita, Koji
    Matsubara, Akio
    JOURNAL OF UROLOGY, 2017, 197 (04): : E183 - E183
  • [36] A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy
    Gross, Evan E.
    Li, Mingjia
    Yin, Ming
    Orcutt, Delaney
    Hussey, Duncan
    Trott, Elliot
    Holt, Sarah K.
    Dwyer, Erin R.
    Kramer, Joel
    Oliva, Kaylee
    Gore, John L.
    Schade, George R.
    Lin, Daniel W.
    Tykodi, Scott S.
    Hall, Evan T.
    Thompson, John A.
    Parikh, Anish
    Yang, Yuanquan
    Collier, Katharine A.
    Miah, Abdul
    Mori-Vogt, Sherry
    Hinkley, Megan
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven K.
    Psutka, Sarah P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (01) : 51.e25 - 51.e31
  • [37] Prediction of the probability of metastatic disease after nephrectomy for renal cell carcinoma: European validation of a multi-institutional nomogram
    Trinh, Quoc-Dien
    Karakiewicz, Pierre J.
    Bhojani, Naeem
    Gallina, Andrea
    Lebeau, Thierry
    Guille, Francois
    Perrotte, Paul
    Lobel, Bernard
    Ficarra, Vincenzo
    Artibani, Walter
    Cindolo, Luca
    Tostain, Jacques
    Abbou, Clement-Claude
    De La Taille, Alexandre
    Patard, Jean-Jacques
    JOURNAL OF UROLOGY, 2007, 177 (04): : 214 - 214
  • [38] Impact of timing of immunotherapy and cytoreductive nephrectomy on outcomes in metastatic renal cell carcinoma: Results from the CKCis database.
    Ghosh, Sunita
    Moria, Feras Ayman
    Wood, Lori
    Bjarnason, Georg A.
    Bhindi, Bimal
    Heng, Daniel Yick Chin
    Castonguay, Vincent
    Pouliot, Frederic
    Kollmannsberger, Christian K.
    Bosse, Dominick
    Basappa, Naveen S.
    Finelli, Antonio
    Fallah-rad, Nazanin
    Breau, Rodney H.
    Lalani, Aly-Khan A.
    Tanguay, Simon
    Graham, Jeffrey
    Saleh, Ramy R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 416 - 416
  • [39] Prediction of the probability of metastatic disease after nephrectomy for renal cell carcinoma: European validation of a multi-institutional nomogram
    Trinh, Q. D.
    Karakiewicz, P.
    Guille, F.
    Perrotte, P.
    Lobel, B.
    Ficarra, V.
    Artibani, W.
    Cindolo, L.
    Tostain, J.
    Abbou, C. C.
    Chopin, D.
    De La Taille, A.
    Patard, J. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 62 - 62
  • [40] Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy
    Tomas Buchler
    Alexandr Poprach
    Targeted Oncology, 2024, 19 : 175 - 180
12345